YuviTal, a digital health startup, has won a breast cancer innovation challenge sponsored by Roche Israel, Startup Nation Central and Sheba Medical Center, the organizations announced on Monday.
The company will receive a 50,000 shekel grant (approximately $13,700) and funding up to 200,000 shekels to conduct a clinical pilot at Sheba’s Breast Cancer Institute in Ramat Gan. YuviTal will also receive an annual membership at ARC, Sheba’s innovation arm, plus mentorship from Roche experts and Sheba oncologists.
YuviTal’s platform collects real-world health data from breast cancer patients, including dietary patterns, activity levels and mood indicators. The system uses AI to provide personalized guidance and alerts clinical teams to potential concerns.
The program, part of Roche’s “Roche for a Better Future” initiative, sought digital solutions to improve treatment adherence and quality of life for breast cancer patients. An advisory committee of oncology experts selected YuviTal from the finalists.
Previous challenge winners include ophthalmology-focused companies Notal Vision and AEYE Health.
Roche Israel General Manager Avi Danziger said the program aims to accelerate digital health innovations that address complex medical challenges.
